Treatment
Zuranolone clinical trials
We’re tracking 2 recruiting studies that include Zuranolone, each written for real people, not researchers, below.
Recruiting studies
- NCT07398469Recruiting
Long-term study of zuranolone for postpartum depression symptoms
This study checks how people with postpartum depression feel over time after starting zuranolone. It uses simple questionnaires to track changes in symptoms.
Cambridge, MassachusettsAges 18 years+ - NCT06759558RecruitingPhase 2
Zuranolone for post-stroke depression
This trial tests a new medicine called zuranolone (allopregnanolone) for people with depression after a stroke. It aims to see if the drug can help improve mood when taken over a short period.
Durham, North CarolinaAges 21–65
What Zuranolone is being studied for
Conditions with recruiting Zuranolone studies.
Common questions
- Are there clinical trials studying Zuranolone?
- Yes. Clin2 currently lists 2 recruiting studies that include Zuranolone, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Zuranolone trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Zuranolone an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Zuranolone or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.